|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Depreciation and amortization | |||||
| Stock-based compensation expense | |||||
| Other expenses | |||||
| Write-down of inventory | |||||
| Loss on convertible notes, net (Note 10) | |||||
| Inventory LCNRV write-downs and losses on firm purchase commitments | |||||
| Gain on equity method investment | |||||
| Loss on convertible notes, net | |||||
| Other non-cash activities | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable, net | |||||
| Inventory | |||||
| Other current assets | |||||
| Other non-current assets | |||||
| Other assets | |||||
| Accounts payable and accrued liabilities | |||||
| Other current liabilities | |||||
| Other non-current liabilities | |||||
| Deferred revenues | |||||
| Other liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of equity securities and short-term investments | |||||
| Sales of equity securities and short-term investments | |||||
| Maturities of short-term investments | |||||
| Capital expenditures | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from stock-based compensation programs | |||||
| Proceeds from issuance of capital stock | |||||
| Proceeds from issuance of long-term debt | |||||
| Repayments of long-term debt | |||||
| Proceeds from issuance of convertible notes | |||||
| Proceeds from funding of 50% interest in Rivian and VW Group Technology, LLC | |||||
| Proceeds from funding of 50% interest in Rivian and Volkswagen Group Technologies, LLC | |||||
| Rivian and Volkswagen Group Technologies, LLC | |||||
| Mind Robotics, Inc. | |||||
| Purchase of capped call options | |||||
| Other financing activities | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net change in cash | |||||
| Cash, cash equivalents, and restricted cash—Beginning of period | |||||
| Cash, cash equivalents, and restricted cash—End of period | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash paid for interest | |||||
| Supplemental disclosure of non-cash investing and financing activities: | |||||
| Capital expenditures included in liabilities | |||||
| Capital stock issued to settle bonuses | |||||
| Conversion of convertible notes | |||||
| Conversion of convertible preferred stock | |||||
Loading...